Ender Soydan

618 total citations
26 papers, 399 citations indexed

About

Ender Soydan is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Ender Soydan has authored 26 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 12 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Ender Soydan's work include Hematopoietic Stem Cell Transplantation (10 papers), Multiple Myeloma Research and Treatments (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Ender Soydan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Multiple Myeloma Research and Treatments (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Ender Soydan collaborates with scholars based in Türkiye, United States and Australia. Ender Soydan's co-authors include Mutlu Arat, Muhıt Özcan, Teru Hideshima, Naoya Mimura, Kenneth C. Anderson, Madhavi Bandi, Yu‐Tzu Tai, Noopur Raje, Nikhil C. Munshi and Sabikun Nahar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Transplantation.

In The Last Decade

Ender Soydan

21 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ender Soydan Türkiye 8 181 140 121 96 94 26 399
Paul Koller United States 9 100 0.6× 163 1.2× 117 1.0× 50 0.5× 23 0.2× 46 369
Entezam Sahovic United States 12 339 1.9× 165 1.2× 157 1.3× 74 0.8× 155 1.6× 30 613
Alissa Visram Canada 12 244 1.3× 198 1.4× 158 1.3× 44 0.5× 53 0.6× 57 403
J.D. Eaton United Kingdom 6 196 1.1× 92 0.7× 90 0.7× 48 0.5× 22 0.2× 7 351
Cheol Won Suh South Korea 9 71 0.4× 129 0.9× 43 0.4× 42 0.4× 51 0.5× 29 275
Poliana Patah United States 11 167 0.9× 133 0.9× 32 0.3× 35 0.4× 59 0.6× 28 379
Nadia Cecconi Italy 12 62 0.3× 90 0.6× 55 0.5× 125 1.3× 111 1.2× 33 402
Mohamed Samra Egypt 10 109 0.6× 84 0.6× 67 0.6× 19 0.2× 46 0.5× 44 296
Maria Paola Simula Italy 11 77 0.4× 44 0.3× 78 0.6× 92 1.0× 88 0.9× 21 387
Kristen Pettit United States 12 320 1.8× 71 0.5× 221 1.8× 45 0.5× 57 0.6× 66 550

Countries citing papers authored by Ender Soydan

Since Specialization
Citations

This map shows the geographic impact of Ender Soydan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ender Soydan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ender Soydan more than expected).

Fields of papers citing papers by Ender Soydan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ender Soydan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ender Soydan. The network helps show where Ender Soydan may publish in the future.

Co-authorship network of co-authors of Ender Soydan

This figure shows the co-authorship network connecting the top 25 collaborators of Ender Soydan. A scholar is included among the top collaborators of Ender Soydan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ender Soydan. Ender Soydan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Seval, Güldane Cengiz, Klara Dalva, Şule Mine Bakanay, et al.. (2021). Post-Induction Undetectable Minimal Residual Disease at 10 -5 Sensitivity Level within Marrow and/or Stem Cell Graft Overrides Cytogenetic High Risk. Blood. 138(Supplement 1). 2909–2909. 1 indexed citations
5.
Seval, Güldane Cengiz, Deniz Şahin, Ender Soydan, et al.. (2018). Comparing Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma Patients. Clinical Lymphoma Myeloma & Leukemia. 18. S306–S306. 1 indexed citations
6.
Soydan, Ender, et al.. (2016). Endoscopic evaluation of acute intestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. The Turkish Journal of Gastroenterology. 27(4). 312–316. 9 indexed citations
8.
Soydan, Ender, Wentao Song, Mariateresa Fulciniti, et al.. (2010). CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells (Blood (2009) 113, 18, (4309-4318)). Blood. 115(14). 5 indexed citations
10.
Akay, Bengü Nisa, et al.. (2010). Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation. Turkish Journal of Hematology. 27(2). 91–98. 3 indexed citations
11.
Bektaş, Mehmet, Ramazan Idılman, İrfan Soykan, et al.. (2008). Adjuvant Therapeutic Plasma Exchange in Liver Failure. Journal of Clinical Gastroenterology. 42(5). 517–521. 24 indexed citations
12.
Soydan, Ender, Klara Dalva, Pervin Topçuoğlu, et al.. (2007). Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra. Transfusion and Apheresis Science. 36(3). 269–273. 8 indexed citations
13.
Topçuoğlu, Pervin, Ender Soydan, Fuat Ekız, et al.. (2007). How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight. Transfusion and Apheresis Science. 36(3). 275–280. 3 indexed citations
14.
Soydan, Ender, Meral Beksaç, Hakan Koç, et al.. (2005). Imatinib only for molecular relapse is not sufficient to achieve a durable complete chimeric status and molecular remission after allo HCT in CML. Biology of Blood and Marrow Transplantation. 11(2). 25–25.
15.
Arat, Mutlu, Ramazan Idılman, Ender Soydan, et al.. (2005). Ursodeoxycholic acid treatment in isolated chronic graft‐vs.‐host disease of the liver. Clinical Transplantation. 19(6). 798–803. 7 indexed citations
16.
Idılman, Ramazan, Esra Erden, Mutlu Arat, et al.. (2005). Trefoil Factor Expression in Biliary Epithelium of Graft-versus-Host Disease of the Liver after Allogeneic Hematopoietic Cell Transplantation. Transplantation. 80(8). 1099–1104. 3 indexed citations
17.
Idılman, Ramazan, Işınsu Kuzu, Esra Erden, et al.. (2005). Evaluation of the effect of transplant-related factors and tissue injury on donor-derived hepatocyte and gastrointestinal epithelial cell repopulation following hematopoietic cell transplantation. Bone Marrow Transplantation. 37(2). 199–206. 4 indexed citations
18.
Idılman, Ramazan, Mutlu Arat, Ender Soydan, et al.. (2004). Lamivudine prophylaxis for prevention of chemotherapy‐induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. Journal of Viral Hepatitis. 11(2). 141–147. 72 indexed citations
19.
Akyerli, Cemaliye Boylu, Meral Beksaç, Michelle Holko, et al.. (2004). Expression of IFITM1 in chronic myeloid leukemia patients. Leukemia Research. 29(3). 283–286. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026